InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Medeva and Georgetown win in SPC rulings

Simon Crompton, London


The Court of Justice of the EU clarified the law on SPCs for combination drugs this morning, but included a sting in the tail for pharma companies

Both pharmaceutical company Medeva and Georgetown University had applications for supplementary protection certificates (SPCs) rejected by the UK IPO.

When both were appealed at the Court of Appeal, the court referred several questions to the Court of Justice (CJ) on...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates

Supplements